Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1

Acute myeloid leukemia (AML) with BCR-ABL1 is rare and has a poor prognosis with conventional chemotherapy or ABL tyrosine kinase inhibitors (TKIs) alone. We reported a case of AML with BCR-ABL1 patient who was successfully treated with dasatinib alone; additionally, we previously reported another c...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Asako, Kondo, Toshinori, Tasaka, Taizo, Yamada, Seiko, Hirose, Tadashi, Fukuda, Hirofumi, Shimizu, Risa, Matsuhashi, Yoshiko, Kondo, Eisei, Wada, Hideho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758353/
https://www.ncbi.nlm.nih.gov/pubmed/33376671
http://dx.doi.org/10.1016/j.lrr.2020.100233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758353/
https://www.ncbi.nlm.nih.gov/pubmed/33376671
http://dx.doi.org/10.1016/j.lrr.2020.100233

Ejemplares similares